Ortho Clinical Diagnostics’ COVID-19 antibody test ready for use after receiving authorization from USFDA

US – Ortho Clinical Diagnostics, one of the world’s largest pure-play in vitro diagnostics companies, received an emergency use authorization (EUA) from the US Food & Drug Administration (FDA) for its VITROS Anti-SARS-CoV-2 IgG Quantitative Test. The new quantitative COVID-19 IgG antibody test is the first quantitative COVID-19 IgG antibody test to receive USFDAs EUA and is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2. Ortho’s VITROS COVID-19 Testing Solutions will help labs meet the demands of the pandemic with reliable, high-throughput…

Read More